Bioavailability of LY03004 and Risperdal® Consta®

Clinical trial NCT02091388 · COMPLETED

Trial details

NCT number: NCT02091388
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2014-09-01
Primary completion: 2015-01-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.